- Home
- »
- Animal Health
- »
-
Veterinary Endotracheal Tubes Market Report, 2026-2033GVR Report cover
Veterinary Endotracheal Tubes Market (2026 - 2033)
Size, Share & Trends Analysis Report By Animal (Dog, Cat), By Product (Cuffed, Uncuffed), By End-use (Hospitals, Clinics), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts
Market Size, 2025
$11.7MMarket Estimate, 2026
$12.7MMarket Forecast, 2033
$23.0MCAGR, 2026–2033
8.9%Veterinary Endotracheal Tubes Market Summary
The veterinary endotracheal tubes market size was valued at USD 11.7 million in 2025 and is projected to grow from USD 12.7 million in 2026 to USD 23.0 million by 2033, at a CAGR of 8.9% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 31.8% in 2025. The increasing prevalence of respiratory diseases in animals, such as the recent outbreak of Canine Infectious Respiratory Disease Complex (CIRDC), significantly drives the market growth.
Source: Grand View Research, IR Documents, Primary Interviews, Paid DatabasesTo learn more about this report,Download Free Sample Report
Key Market Trends & Insights
- By product: Cuffed veterinary endotracheal tubes held the largest market in 2025 with 65.7% share.
- By animal: Dog segment accounted for 44.2% of revenue share in 2025.
- By end use: The hospitals segment dominated the market in 2025 with 61.1% share
Regional Highlights
- Largest regional market: North America (31.8% revenue share, 2025)
- By country: The U.S. held the largest market share in 2025.
Market Size & Forecast
- Market size in 2025: 11.7 Million
- Estimated market size in 2026: USD 12.7 Million
- Projected market size by 2035: USD 23.0 Million
- CAGR (2026-2033): 8.9%
Prism AI by Grand View Research Free to tryAsk a question about the veterinary endotracheal tubes marketTry asking✓Every figure cited from GVR research Prefer the report? Download free sample →
According to the data published in February 2024, during the latter half of 2023, states such as Oregon, Colorado, California, Florida, and New Hampshire, along with parts of Canada, reported a rise in cases of canine respiratory illnesses, including pneumonia. For example, Colorado State University's Veterinary Teaching Hospital observed more than double the cases of canine pneumonia from September to November 2023 compared to the same period in 2022. These outbreaks highlight the critical need for advanced airway management tools, such as veterinary endotracheal tubes, to support animals with compromised respiratory systems during treatment and recovery. As veterinarians handle increasing caseloads of respiratory diseases, the demand for reliable and effective endotracheal tubes is expected to rise, helping ensure adequate ventilation and prevent complications during medical procedures.
To learn more about this report,Download Free Sample Report
In addition, technological advancements in veterinary equipment also fuel product adoption and promote market growth. Manufacturers are increasingly developing innovative endotracheal tubes with improved flexibility, reinforced materials, and cuff designs that reduce the risk of complications such as airway injuries and aspiration. These innovations cater to a variety of animal sizes and species, making the devices more versatile and effective. In addition, the integration of disposable and eco-friendly materials addresses concerns about infection control and environmental sustainability, which are becoming increasingly important in modern veterinary practices.
The expansion of veterinary services and facilities further supports the growth of the veterinary endotracheal tube industry. Governments and private organizations are investing in the development of animal healthcare infrastructure, leading to increased availability and affordability of veterinary care. Furthermore, the rising focus on livestock health and welfare, driven by the agriculture and dairy industries, contributes to the demand for endotracheal tubes in veterinary medicine. For instance, the Oregon Department of Agriculture (ODA), along with OSU’s Carlson College of Veterinary Medicine, the Oregon Veterinary Diagnostic Laboratory, the USDA’s National Veterinary Services Laboratory, and other specialists, together investigated the causative agent behind the respiratory disease outbreak in canines. This combination of factors ensures steady growth for the market, catering to both companion animals and farm animals.
Market Dynamics
The veterinary endotracheal tubes market is experiencing steady growth, supported by rising pet ownership, increasing veterinary surgical volumes, growing awareness regarding anesthesia safety, and expanding spending on companion animal healthcare. The market is also benefiting from technological improvements in tube materials, cuff designs, and airway management protocols. However, pricing pressures, limited availability of skilled veterinary anesthetists in developing regions, and the relatively small market size compared to human airway management continue to moderate growth potential. The competitive landscape remains fragmented, with established medical device manufacturers and specialized veterinary suppliers pursuing innovation and geographic expansion strategies.
The growing global companion animal population and increasing expenditure on veterinary care are major factors driving demand for veterinary endotracheal tubes. Dogs represented over 40.0% of market revenue in 2025, reflecting their high utilization in surgical and critical care procedures. The increasing prevalence of respiratory disorders, dental procedures, orthopedic surgeries, tumor removals, and emergency interventions has significantly increased anesthesia usage across veterinary settings. Furthermore, outbreaks of respiratory conditions such as Canine Infectious Respiratory Disease Complex (CIRDC) have heightened awareness around advanced airway management and ventilation support. Veterinary hospitals and specialty clinics are increasingly adopting cuffed endotracheal tubes because of their ability to provide secure airway sealing, minimize aspiration risks, and improve ventilation efficiency during prolonged procedures. Growing pet insurance penetration, rising willingness among owners to pursue advanced treatments, and increasing investments in veterinary infrastructure are expected to sustain long-term demand for airway management products globally.
Despite favorable growth prospects, the market faces challenges from cost-conscious veterinary practices and uneven access to specialized anesthesia expertise. Many small clinics, particularly in emerging markets, continue to prioritize affordability over premium airway management products, limiting adoption of advanced tube technologies. In addition, veterinary intubation requires species-specific expertise due to significant anatomical differences among dogs, cats, rodents, and exotic animals. Improper tube selection or placement may result in airway trauma, aspiration complications, or ventilation inefficiencies. These challenges create a dependency on trained veterinary anesthetists, whose availability remains limited across many developing regions. The relatively small overall market size-estimated at approximately USD 10.9 million globally in 2024-also reduces incentives for extensive R&D investments compared to human airway management devices. Consequently, product innovation and adoption rates may vary considerably across geographies and end-user segments.
Analyst Perspective
The veterinary endotracheal tubes market is expected to maintain healthy growth through 2030, supported by rising companion animal ownership, increasing surgical intervention rates, and continued advancements in veterinary anesthesia practices. Demand is likely to shift toward cuffed and premium-material tubes as veterinary professionals place greater emphasis on airway safety, ventilation efficiency, and procedural outcomes. Emerging opportunities are expected to arise from specialty veterinary hospitals, exotic animal care, and expanding pet healthcare infrastructure across Asia-Pacific and Latin America. Over the medium term, manufacturers that combine product innovation, species-specific solutions, and broader distribution reach will be best positioned to capture market share in this fragmented but steadily expanding market.
Animal Insights
The dog segment accounted for 44.2% of revenue share in 2025, driven by the high global population of pet dogs and their significant share in veterinary healthcare services. According to the American Pet Products Association, there were over 65.1 million pet dogs in the United States alone in 2023, highlighting the widespread adoption of dogs as companion animals. Dogs often require veterinary care for surgical procedures, anesthesia, and respiratory management, all of which necessitate the use of endotracheal tubes. In addition, the increasing awareness of canine health and the availability of advanced medical treatments for conditions such as brachycephalic airway syndrome and other respiratory disorders contribute to the dominance of the dog segment in this market. The growing emphasis on improving surgical outcomes and ensuring airway safety in dogs further strengthens their position as leaders in the veterinary endotracheal tube industry.
The cat segment is projected to grow at a CAGR of 9.01% from 2025 to 2030. This growth is attributed to an increase in cat adoptions and a growing focus on feline health care. According to the data published in November 2024 by the American Veterinary Medical Association, cats are the second most popular pet in the United States, with over 73.8 million pet cats reported in recent years. Feline-specific health challenges, such as asthma, airway obstructions, and respiratory infections, have highlighted the need for precise and specialized medical interventions, including the use of appropriately sized endotracheal tubes. In addition, advancements in veterinary anesthesia techniques and growing awareness among cat owners about the benefits of preventive and surgical care are boosting the demand for endotracheal tubes tailored for cats. The segment's rapid growth is further supported by innovations in tube design, which ensure better compatibility and safety for smaller airway anatomies.
Product Insights
Cuffed veterinary endotracheal tubes held the largest market in 2025 with 65.7% share. Cuffed tubes are especially favored for use in larger animals and during prolonged procedures that require enhanced safety measures. In addition, their effectiveness in reducing complications such as ventilator-associated pneumonia has made them the preferred choice among veterinarians. For instance, Medtronic’s Shiley Cuffed Basic Endotracheal Tube features enhanced functionality and safety. These tubes, which cater to various patient sizes, including infants, pediatric, and adult patients, offer critical benefits such as latex-free materials, ensuring compatibility with sensitive patients. Features like radiopaque markers facilitate accurate placement, while the inflatable cuff provides a secure airway seal to prevent aspiration and ensure effective ventilation during procedures. The sterile and high-quality design of these tubes aligns with the stringent safety and reliability requirements in veterinary practices, further solidifying their dominance in the market.
The uncuffed veterinary endotracheal tubes segment is expected to grow with a significant CAGR during the forecast period. This growth is primarily due to their increasing use in small animals, neonates, and certain avian species. These tubes are particularly advantageous in scenarios where airway anatomy is delicate, as they reduce the risk of tracheal trauma and pressure-related injuries. The demand for uncuffed tubes is driven by their simplicity, cost-effectiveness, and suitability for short-duration procedures with minimal aspiration risk. In addition, the growing adoption of minimally invasive techniques in veterinary care and the rising focus on specialized care for smaller pets have boosted the use of uncuffed tubes, thereby propelling market growth.
End Use Insights
The hospitals segment dominated the market in 2025 with 61.1% share, driven by the higher number of complex surgical procedures and critical care cases handled in these facilities. Veterinary hospitals are equipped with advanced medical infrastructure and skilled professionals capable of managing a wide range of conditions requiring endotracheal intubation, including surgeries, respiratory support, and emergency airway management. The availability of specialized departments and intensive care units in hospitals further enhances their capacity to use endotracheal tubes effectively. In addition, hospitals often serve as referral centers for complex cases, ensuring consistent demand for high-quality airway management devices, including endotracheal tubes, to accommodate diverse animal species and sizes.
To learn more about this report,Download Free Sample Report
The clinics segment is projected to grow at the fastest CAGR over the forecast period, owing to the increasing number of small and mid-sized veterinary clinics globally. These clinics handle a significant share of routine surgeries, anesthesia procedures, and emergency care for companion animals, all of which are key applications for endotracheal tubes. The rising trend in pet ownership, coupled with a growing preference for accessible, localized veterinary services, has expanded the role of clinics in delivering quality healthcare. Advances in medical equipment and affordable endotracheal tube options have further enabled clinics to adopt these tools for a broader range of procedures. In addition, the growing focus on preventive care and early intervention at the clinic level has increased the need for reliable airway management solutions, fueling the segment's rapid growth.
Regional Insights
North America veterinary endotracheal tubes market held the largest revenue share globally at 31.8% in 2025. This dominance is attributed to factors such as a growing number of insured pets and an advanced veterinary healthcare system. In Canada, for instance, the total number of insured pets grew by 13.6%, with an average annual growth rate of 17.6% since 2019. This trend highlights the increasing investment in pet healthcare by owners, particularly for dogs, which account for 75.5% of insured pets, and for cats, at 24.5%. Moreover, robust infrastructure and the willingness of pet owners to invest in high-quality care have solidified North America's market.
To learn more about this report,Download Free Sample Report
U.S. Veterinary Endotracheal Tubes Market Trends
The veterinary endotracheal tubes market in the U.S. held the largest share in the North America region in 2025 due to the increasing demand for advanced veterinary care and a rising number of surgical procedures performed on animals. According to the American Pet Products Association (APPA), over 70% of U.S. households own pets, driving a growing need for veterinary services, including airway management during surgeries and in critical care. In addition, the U.S. has a well-established network of veterinary clinics, hospitals, and emergency care centers that rely heavily on endotracheal tubes for anesthesia and respiratory support, thus increasing adoption and thereby propelling market growth.
Europe Veterinary Endotracheal Tubes Market Trends
Europe veterinary endotracheal tubes market was identified as a lucrative region in 2024. The region benefits from a strong presence of key players in the industry, supported by local players such as Ace Vets Supplies. The market is also driven by the availability of innovative products designed to improve the efficiency and safety of airway management in animals. For instance, Vet tubes are the first disposable endotracheal tubes in the European market, specifically designed for small pets. These tubes are better suited to the anatomy of pets, minimize the risk of damage to sensitive tissues, reduce the likelihood of tube damage when maneuvering around sharp teeth, and enhance ease of intubation. Furthermore, the tubes' features-such as harmless PVC material, a high-volume low-pressure cuff, and an innovative inflation system-highlight the region's commitment to advancing veterinary care through safer, more effective tools.
The UK veterinary endotracheal tubes market is propelled by the country’s focus on advancing animal healthcare, supported by organizations like Veterinary Instrumentation, which has been at the forefront of the veterinary community for over three decades and plays a significant role in driving the market growth. In addition, growing awareness of animal welfare and the increasing demand for specialized veterinary services contribute to the adoption of such cutting-edge solutions in the UK. A key example is the Safe-Seal ET Tube, which features the Blaine Bafflex System, offering a unique design that eliminates the need for an inflation cuff to seal the tube in the trachea. This innovation reduces the risk of pressure-related damage to the trachea and improves overall airway management during veterinary surgeries.
Asia Pacific Veterinary Endotracheal Tubes Market Trends
The Asia Pacific veterinary endotracheal tubes market is anticipated to grow at the fastest CAGR of 9.81% during the forecast period, driven by several factors, including the increasing demand for veterinary care due to rising pet ownership, growing livestock industries, and expanding veterinary infrastructure. The region has witnessed a significant rise in the number of pet owners, particularly in countries such as China, Japan, and South Korea, where pets are increasingly considered family members. This has led to a growing need for advanced veterinary services, including surgeries that require endotracheal tubes for proper anesthesia and respiratory support. The expansion of veterinary hospitals and clinics across the Asia-Pacific, along with improvements in animal healthcare practices, is a key driver of the market's growth in the region.
The veterinary endotracheal tube market in Japan is driven by the country’s high pet ownership rates, advancements in veterinary care, and a strong emphasis on animal welfare. According to the Japan Pet Food Association, Japan has one of the highest pet ownership rates in Asia, with millions of households owning dogs and cats, which increases the demand for veterinary services, including surgeries and anesthesia procedures that require endotracheal tubes.
Latin America Veterinary Endotracheal Tubes Market Trends
The Latin America veterinary endotracheal tubes market is driven by steadily rising pet ownership in countries such as Brazil and Argentina, leading to greater demand for veterinary care, including surgical procedures requiring endotracheal tubes for anesthesia and respiratory support. In addition, the growing middle class and rising disposable incomes have enabled more pet owners to seek advanced veterinary care for their animals, contributing to the market’s growth.
The veterinary endotracheal tube market in Brazil is primarily driven by the country's growing pet population, increased demand for veterinary care, and advancements in veterinary medicine. Brazil has one of the largest pet populations in the world, with millions of households owning dogs, cats, and other pets, creating a strong need for veterinary services, including surgeries and emergency procedures that require endotracheal tubes for safe anesthesia and respiratory support. The rising awareness of animal health, particularly regarding respiratory diseases and the benefits of advanced medical treatments, is also contributing to the market growth.
MEA Veterinary Endotracheal Tubes Market Trends
The veterinary endotracheal tube market in the Middle East and Africa is driven by several key factors, including the region's emphasis on livestock health, particularly in countries with large agricultural sectors like South Africa and Egypt, which further supports the need for veterinary endotracheal tubes in farm animal care. Improvements in veterinary infrastructure, coupled with rising disposable incomes and a growing middle class, also contribute to the market expansion. Furthermore, greater awareness of respiratory diseases and advancements in animal healthcare are encouraging the use of advanced veterinary equipment, including endotracheal tubes, in both companion animals and livestock management.
Saudi Arabia's veterinary endotracheal tubes market is primarily driven by growing investments in the country’s veterinary infrastructure, with a notable increase in the number of veterinary clinics and hospitals offering advanced medical services. The government’s focus on improving animal health, for both pets and livestock, has led to increased demand for high-quality medical equipment, including endotracheal tubes, to ensure proper respiratory management during procedures.
Key Veterinary Endotracheal Tubes Company Insights
The veterinary endotracheal tubes industry is relatively competitive and fragmented, with both small and large companies. Moreover, companies are increasingly adopting strategies such as mergers and acquisitions, geographic expansion, and product launches to expand their market share. Owing to ongoing research initiatives, this industry is considered to be moderate to highly innovative.
Key Veterinary Endotracheal Tubes Companies:
The following are the leading companies in the veterinary endotracheal tubes market.
-
Medtronic
-
Conduct Science
-
Harvard Apparatus (Harvard Bioscience Inc.)
-
Jorgensen Laboratories
-
Vetamac, Inc.
-
RWD Life Science Co., LTD
Competitive Benchmarking
Category
Operating Strategies
Competitive Edge
Weakness
Established Players (Medtronic, Harvard Bioscience, Jorgensen Laboratories, Conduct Science)
- Expand product portfolios through innovation in cuffed tube designs, safety markers, and anesthesia accessories.
- Strengthen distribution through veterinary hospital networks, specialty clinics, and international channel partnerships.
- Strong brand recognition and established relationships with veterinary practitioners.
- Broad product ecosystems enabling bundled airway management and anesthesia solutions.
- Higher pricing compared with value-focused competitors may limit penetration in emerging markets.
- Larger organizational structures can slow product customization and response to niche veterinary requirements.
Emerging Players (Vetamac Inc., RWD Life Science Co. Ltd.)
- Target niche applications through species-specific and procedure-specific airway management products.
- Compete through flexible pricing, digital sales channels, and regional distributor partnerships.
- Faster product development cycles and greater agility in addressing unmet clinical needs.
- Ability to offer cost-effective alternatives for small veterinary practices.
- Limited global distribution infrastructure and lower brand visibility.
- Greater dependence on third-party distributors and narrower product portfolios.
Recent Developments
-
In March 2024, Medline Industries acquired the manufacturing rights and intellectual property of AG Cuffill from Hospitech Respiration, strengthening its airway management portfolio. It enhances precision in airway management, offering safer cuff pressure monitoring for endotracheal tubes, with applications in veterinary care to improve patient outcomes.
-
In November 2022, MILA International, Inc. launched a new endotracheal tube designed to deliver anesthetic gases, support ventilation, and obtain lower airway samples. The tube features a distal sampling port for easy sample collection without disconnecting the system, and a universal connector compatible with most large-animal breathing systems. It is available in eight sizes.
Veterinary Endotracheal Tubes Market Report Scope
Report Attribute
Details
Market size in 2025
USD 11.7 million
Estimated market size in 2026
USD 12.7 million
Projected market size by 2033
USD 23.0 million
Growth rate
CAGR of 8.9% from 2026 to 2033
Historical data
2021 - 2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million/billion and CAGR from 2026 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Animal, product, end use, region
Regional scope
North America; Europe; Asia Pacific; Latin America; MEA
Country scope
U.S.; Canada; Mexico; Germany; UK; France; Italy; Spain; Norway; Denmark; Sweden; China; Japan; India; South Korea; Australia; Thailand; Singapore; Brazil; Argentina; Saudi Arabia; South Africa; UAE; Kuwait
Key companies profiled
Medtronic, Conduct Science, Harvard Apparatus (Harvard Bioscience Inc.), Jorgensen Laboratories, Vetamac, Inc., RWD Life Science Co., LTD
Customization scope
Free report customization (equivalent up to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Global Veterinary Endotracheal Tubes Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global veterinary endotracheal tubes market report based on animal, product, end use, and region:
To learn more about this report,Download Free Sample Report
-
Animal Outlook (Revenue, USD Million, 2021 - 2033)
-
Dog
-
Cat
-
Others (Rats, Mouse, Gunnie Pig, etc.)
-
-
Product Outlook (Revenue, USD Million, 2021 - 2033)
-
Cuffed
-
Uncuffed
-
-
End Use Outlook (Revenue, USD Million, 2021 - 2033)
-
Hospitals
-
Clinics
-
-
Regional Outlook (Revenue, USD Million, 2021 - 2033)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Denmark
-
Sweden
-
Norway
-
-
Asia Pacific
-
China
-
Japan
-
India
-
South Korea
-
Australia
-
Thailand
-
-
Latin America
-
Brazil
-
Argentina
-
-
Middle East and Africa (MEA)
-
Saudi Arabia
-
UAE
-
South Africa
-
Kuwait
-
-
Research Methodology
The veterinary endotracheal tubes market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing - reconciling supply-side and demand-side estimates - and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each veterinary endotracheal tubes segment quantified using the revenue-capture definitions in the table below.
Segment Definition
Segment Category
Segment
Definition
Animal Type
Dog
Endotracheal tubes used during anesthesia and respiratory management procedures in canine patients.
Animal Type
Cat
Tubes specifically designed for feline airway anatomy and veterinary interventions.
Animal Type
Others
Includes rodents, rabbits, guinea pigs, ferrets, birds, reptiles, and other companion or research animals.
Product
Cuffed
Endotracheal tubes equipped with an inflatable cuff that creates a tracheal seal, reducing aspiration risk and improving ventilation control.
Product
Uncuffed
Tubes without an inflatable cuff, commonly used in small animals and cases where minimizing tracheal trauma is critical.
End Use
Hospitals
Large veterinary hospitals and specialty centers performing advanced surgeries, critical care, and emergency procedures.
End Use
Clinics
General veterinary clinics and outpatient facilities performing routine surgical and diagnostic procedures.
Delivered Customizations
This report has been delivered with the following In-depth customizations
Client Request
Customization Delivered
Value Add
Competitive benchmarking of veterinary airway management suppliers
Comparative assessment of market positioning, product portfolios, pricing strategies, and distribution footprints
Supports supplier selection, partnership evaluation, and competitive intelligence
Species-wise procedure analysis
Detailed analysis of endotracheal tube utilization across dogs, cats, rodents, equine, and exotic animals
Identifies high-growth clinical opportunities and demand hotspots
Veterinary hospital procurement assessment
Evaluation of purchasing criteria, replacement cycles, and buying behavior across hospitals and clinics
Enhances go-to-market and sales strategy development
Frequently Asked Questions About This Report
Several prominent companies, including MMedtronic, Conduct Science, Harvard Apparatus (Harvard Bioscience Inc.), Jorgensen Laboratories, Vetamac, Inc., RWD Life Science Co., LTD compete for market share in the veterinary endotracheal tubes market
Key drivers contributing to this growth include rising hospitalization & surgical procedures coupled with pet insurance adoption, rising pet expenditure, increasing prevalence of respiratory diseases in animals, such as the recent outbreak of Canine Infectious Respiratory Disease Complex (CIRDC) and critical care visit. The pet population has increased significantly over the past few years due to the increasing number of households that want to adopt a pet for a better quality of life.
Cuffed veterinary endotracheal tubes held the largest market in 2025 with 65.7% share.
The hospitals segment dominated the market in 2025 with 61.1% share, driven by the higher number of complex surgical procedures and critical care cases handled in these facilities
The global veterinary endotracheal tubes market size was valued at USD 11.7 million in 2025 and is estimated at USD 12.7 million for 2026.
The global veterinary endotracheal tubes market is expected to grow at a CAGR of 8.9% from 2026 to 2033, reaching USD 23.0 million by 2033.
The dog segment accounted for 44.2% of revenue share in 2025, driven by the high global population of pet dogs and their significant share in veterinary healthcare services.
About the Author(s)
Animal Health Research Team
Healthcare · Animal HealthThis report was authored by the animal health research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the animal health segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.
Last Updated:
Speak to Analyst
Customize this report to your needs - add regions, segments, or data points, with 20% free customization.
Or view our licence options:
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.